Lundin Law PC announces a class action lawsuit has been filed against
Rockwell Medical, Inc. (“Rockwell” or the “Company”) (Nasdaq:
RMTI) concerning possible violations of federal securities laws between
September 9, 2015 and February 29, 2016. Investors who purchased or
otherwise acquired shares during the Class Period should contact the
Firm in advance of the May 3, 2016, lead plaintiff motion deadline.
For more information or to participate, please
contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or
via e-mail at brian@lundinlawpc.com.
No class has been certified in the above action. Until a class is
certified, you are not considered represented by an attorney. You may
also choose to do nothing and be an absent class member.
According to the complaint, the Company failed to disclose that: (1)
Rockwell’s main product offering for Triferic has not yet been approved
by the FDA; and (2) Rockwell is seeking to obtain transitional add-on
payment reimbursement for Triferic with the Centers for Medicare &
Medicaid Services instead of bundled reimbursement.
Lundin Law PC was created by Brian Lundin, a securities litigator based
in Los Angeles.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160330006439/en/
Copyright Business Wire 2016